Qube Research & Technologies (QRT)’s Oric Pharmaceuticals ORIC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.6M	Sell	794,542 -64,949	-8%	-$589K	0.01%	1366
2026 Q1	$10.9M	Sell	859,491 -345,938	-29%	-$3.93M	0.01%	1226
2025 Q4	$9.86M	Buy	+1,205,429	New	+$13.9M	0.01%	1354
2024 Q3	–	Sell	-81,227	Closed	-$574K	–	3892
2024 Q2	$574K	Buy	81,227 +28,184	+53%	+$252K	﹤0.01%	2100
2024 Q1	$729K	Buy	+53,043	New	+$630K	﹤0.01%	2331
2023 Q2	–	Sell	-67,466	Closed	-$385K	–	2828
2023 Q1	$385K	Buy	67,466 +27,778	+70%	+$145K	﹤0.01%	1656
2022 Q4	$234K	Buy	39,688 +14,028	+55%	+$47.4K	﹤0.01%	1745
2022 Q3	$82K	Sell	25,660 -5,393	-17%	-$21.6K	﹤0.01%	2028
2022 Q2	$139K	Buy	+31,053	New	+$124K	﹤0.01%	1827
2021 Q3	–	Sell	-22,512	Closed	-$398K	–	2626
2021 Q2	$398K	Buy	+22,512	New	+$493K	﹤0.01%	1401

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s ORIC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Oric Pharmaceuticals (ORIC) stake by 7.6% in Q2 2026, selling an estimated $589K and leaving 794,542 shares worth $8.6M. The position accounts for 0.01% of the portfolio, ranked #1366.

Qube Research & Technologies (QRT) first reported a position in ORIC in Q2 2021 and has held it in 10 quarters since. The position peaked at $10.9M in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Qube Research & Technologies (QRT) held 794,542 shares of Oric Pharmaceuticals worth $8.6M as of Q2 2026.
Qube Research & Technologies (QRT) sold 64,949 Oric Pharmaceuticals shares in Q2 2026, an estimated $589K.
Oric Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1366 holding.
Qube Research & Technologies (QRT) first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Oric Pharmaceuticals position peaked at $10.9M in Q1 2026.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.